language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
CECE

$49.94

+0.81
arrow_drop_up1.65%
Market closed·update27 Feb 2026 21:00

$48.98

-0.96
arrow_drop_down1.92%
Post-market·update27 Feb 2026 23:49
Day's Range
47.8425-50.345
52-week Range
35.13-63.55

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2026-02-17
Next Earnings TimeAfter Market Close
Volume2.44M
Average Volume 30d2.22M

AI CE Summary

Powered by LiveAI
💰
-3.4
Valuation (P/E Ratio)
Current P/E is negative due to recent net losses. Historical P/E (2023) was 3.2, indicating potential undervaluation if losses are temporary.
📈
-0.152
EPS Growth (YoY)
Recent EPS performance shows a significant decline (e.g., EPS TTM is -15.12 vs. prior periods). Need to analyze the reasons for the negative EPS.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Neutral
68

Celanese Corporation shows mixed signals. Fundamentals are impacted by recent losses, while technicals suggest a near-term downtrend. Thematic alignment is moderate. Caution is advised for new positions, while existing holders may consider rebalancing.

Neutral

Thematic

65

Celanese operates in cyclical chemical and specialty materials sectors. While some of its products serve growing end-markets (e.g., automotive, medical), the overall thematic exposure is moderately positive but not a strong growth driver.

Neutral

Fundamental

62

Celanese faces significant headwinds with recent net losses and negative EPS trends. While revenue has been volatile, debt levels are substantial. The dividend yield offers some return, but profitability metrics are concerning.

Bearish

Technical

55

Celanese is exhibiting bearish technical signals across multiple timeframes. The price is below key moving averages, momentum indicators are weak, and trading volume suggests selling pressure.

FactorScore
Sustainable Materials70
Industrial Automation & Advanced Manufacturing75
Energy Transition50
Consumer Staples & Healthcare60
Economic Sensitivity55
FactorScore
Valuation70
Profitability15
Growth25
Balance Sheet Health30
Cash Flow55
Dividends75
FactorScore
Trend Analysis15
Momentum40
Volume Confirmation45
Support & Resistance50
Short-term Oscillators40

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (6)

Earnings Performance chevron_right

Positive EPS Surprise

The company has exceeded earnings per share (EPS) estimates in 7 of the last 12 quarters, indicating consistent operational performance and potential for future earnings beats.

Valuation chevron_right

Attractive P/S Ratio

The Price-to-Sales (P/S) ratio of 0.8 is below the industry average of 1.5, suggesting the company is undervalued relative to its revenue generation capabilities compared to peers.

Show More 🔒
thumb_down

Bearish Points (8)

Earnings Performance chevron_right

Negative EPS Surprise

The company missed EPS estimates in the last two quarters, with the most recent miss being -14.43% and -12.12%, suggesting potential headwinds in earnings generation.

Valuation chevron_right

Negative P/E Ratio

The TTM P/E ratio is -3.4, and the 2024 P/E ratio is -5.0, indicating the company is currently unprofitable, which can pose a valuation risk.

Show More 🔒

Calendar

July 2025

29

Ex-Dividend Date

August 2025

11

Next Dividend Date

August 2025

12

Next Earnings Date

EPS Est.
Revenue Est.

H: $1.49

A: $1.40

L: $1.30

H: 2.60B

A: 2.49B

L: 2.40B

Profile

Employees (FY)11K
ISIN-
FIGI-

Celanese Corporation, a chemical and specialty materials company, manufactures and sells engineered polymers worldwide. The Engineered Materials segment offers nylon and polypropylene compounds and formulations, high temperature nylon, polyoxymethylene, polyethylene and polybutylene terephthalates, ultra-high molecular weight polyethylene, long-chain polyamides, long-fiber reinforced thermoplastics, liquid crystal polymers, thermoplastic elastomers and vulcanizates, polyphenylene sulfide, ethylene vinyl acetate pharmaceutical grade copolymers, and ethylene acrylic elastomers for use in automotive, medical, industrial, energy storage, consumer electronics, appliance, construction, filtration equipment, telecommunication, beverage, electrical, and consumer apparel applications. Its Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, vinyl acetate ethylene emulsions, conventional emulsions, ethylene vinyl acetate resins and compounds, low-density polyethylene resins, redispersible powders, acetic anhydride, ethyl acetates, formaldehydes, butyl acetates, acetate tows, and acetate flakes for use in paints, coatings, adhesives, textiles, paper finishing, flexible packaging, lamination products, pharmaceuticals, films, inks, plasticizers, solvents, automotive parts, external thermal insulation composite systems, tiling, plasters and renders, lubricants, filtration, food and beverage, consumer goods, and food packaging applications. The company offers its products under the Celanyl, FRIANYL, ECOMID, Zytel, Celcon, Hostaform, Celanex, Crastin, Thermx, Rynite, GUR, Celstran, Factor, Vectra, Zenite, Forprene, Sofprene, Laprene, Hytrel, Santoprene, Dytron, Geolast, Vamac, Polifor, Tecnoprene, and VitalDose brands. It sells its products directly to customers and through distributors; and serves original equipment manufacturers and suppliers. Celanese Corporation was founded in 1912 and is headquartered in Irving, Texas.

Seasonals

2025
2024
2023
2022
2021

Price Target

65.71 USD

The 39 analysts offering 1 year price forecasts for CE have a max estimate of 110.00 and a min estimate of 47.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
100M (91.68%)
Closely held shares
9.1M (8.32%)
109M
Free Float shares
100M (91.68%)
Closely held shares
9.1M (8.32%)

Capital Structure

Market cap
6.25B
Debt
12.95B
Minority interest
0.00
Cash & equivalents
962M
Enterprise value
18.24B

Valuation - Summary

Market Cap
6.25B
Net income
-1.82B(-29.12%)
Revenue
7.41B(118.57%)
6.25B
Market Cap
6.25B
Net income
-1.82B(-29.12%)
Revenue
7.41B(118.57%)
Price to earning ratio (P/E)-3.40x
Price to sales ratio (P/S)0.80x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
10.28B
COGS
7.92B
Gross Profit
2.36B
OpEx
1.32B
Operating Income
1.04B
Other & Taxes
2.56B
Net Income
-1.52B

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒